While normalizing mitochondrial ROS by modest level of mCAT expression attenuates cardiac defects in a model of mitofusin-deficient cardiomyopathy, super-suppression of mitochondrial ROS by high level of mCAT expression exacerbates the defects (Song et al., 2014). This evidence concerns the gene MCAT and cardiomyopathy.